KCNQ1OT1 and myeloid sarcoma: These results suggest for the first time that the lncRNA NEAT1 and the lncRNA KCNQ1OT1 influence MS pathogenesis through an imbalance between Th17 and Treg and can be considered a potential anti‐inflammatory target.